Dr. Brian Litt, MD

Dr. Litt practices at Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania.

Dr. Litt's NPI, 1932131273, was assigned on July 7, 2006. Dr. Litt graduated from Johns Hopkins University School of Medicine in 1986. Dr. Litt holds Pennsylvania license MD068193L.

Dr. Litt's primary practice is Perelman Center for Advanced Medicine, at 3400 Civic Center Blvd Fl 2 Fl 2, Philadelphia, PA 19104. The practice phone is (215) 615-4949.

Dr. Litt's primary practice is Perelman Center For Advanced Medicine in Philadelphia, Pennsylvania. Dr. Litt is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Litt to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Litt practices, 4 sites in all. Vendor and product names are available with a free account.

Epilepsy is Dr. Litt's primary specialty in the NPI Registry, under taxonomy code 2084E0001X. Dr. Litt is licensed in Pennsylvania.

CMS data shows 93 Medicare services from Dr. Litt across 4 procedure codes in 2024, for 70 Medicare patients. Medicare paid $8,515 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 70 Medicare patients who saw Dr. Litt in 2024. The largest group is 65 to 74, with 28 patients. 71% of them have high blood pressure, and 66% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Litt's median patient age at 44, with 55% women.

In 2024, Dr. Litt wrote 219 Medicare Part D claims for 44 patients. 53% of them were for generic drugs. CMS names the drug for 114 of them, across 4 drugs with 11 or more claims each, at $91,563 in total drug cost. In 2023, CMS named 115 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Litt for performance year 2024, reported as part of a group. Dr. Litt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 130 papers to Dr. Litt, published from 2010 to 2025. 2023 was the busiest year, with 14. The most frequent topics are Electroencephalography, Epilepsy and Seizures. Dr. Litt has published most often in Epilepsia. Dr. Litt's most frequent co-authors are Erin Caitlin Conrad, MD, Joel M. Stein, MD and Steven Nicholas Baldassano, MD.

CMS Open Payments shows 24 general payments to Dr. Litt from 6 drug and device companies from 2016 to 2021. Consulting fees make up the largest share, 88% of the total. UCB, Inc. paid the most, $5,988. It also lists 1 research payment totaling $45,200 in 2023.

Dr. Litt graduated from Johns Hopkins University School of Medicine in 1986.